de Cristofaro Tiziana, Di Palma Tina, Fichera Imma, Lucci Valeria, Parrillo Luca, De Felice Mario, Zannini Mariastella
Institute of Experimental Endocrinology and Oncology G. Salvatore, National Research Council, 80131 Napoli, Italy.
Mol Endocrinol. 2012 Jan;26(1):67-78. doi: 10.1210/me.2011-1090. Epub 2011 Dec 1.
Cadherin-16 was originally identified as a tissue-specific cadherin present exclusively in kidney. Only recently, Cadherin-16 has been detected also on the plasma membrane of mouse thyrocytes. This last finding prompted us to note that the expression profile of Cadherin-16 resembles that of the transcription factor Pax8, a member of the Pax (paired-box) gene family, predominantly expressed in the developing and adult kidney and thyroid. Pax8 has been extensively characterized in the thyroid and shown to be a master gene for thyroid development and differentiation. In this study, we determined the role of the transcription factor Pax8 in the regulation of Cadherin-16 expression. We demonstrate that the Cadherin-16 minimal promoter is transcriptionally active in thyroid cells as well as in kidney cells, that Pax8 is able to activate transcription from a Cadherin-16 promoter reporter construct, and more importantly, that indeed Pax8 is able to bind in vivo the Cadherin-16 promoter region. In addition, by means of Pax8 RNA interference in thyroid cells and by analyzing Pax8 null mice, we demonstrate that Pax8 regulates also in vivo the expression of Cadherin-16. Finally, we reveal that the expression of Cadherin-16 is TSH dependent in FRTL-5 thyroid cells and significantly reduced in mouse thyroid carcinomas. Therefore, we conclude that Cadherin-16 is a novel downstream target of the transcription factor Pax8, likely since the early steps of thyroid development, and that its expression is associated with the fully differentiated state of the thyroid cell.
钙黏蛋白-16最初被鉴定为一种仅在肾脏中存在的组织特异性钙黏蛋白。直到最近,才在小鼠甲状腺细胞的质膜上也检测到了钙黏蛋白-16。这一最新发现促使我们注意到,钙黏蛋白-16的表达谱与转录因子Pax8相似,Pax8是Pax(配对盒)基因家族的成员,主要在发育中的和成年的肾脏及甲状腺中表达。Pax8在甲状腺中已得到广泛研究,并被证明是甲状腺发育和分化的主控基因。在本研究中,我们确定了转录因子Pax8在调节钙黏蛋白-16表达中的作用。我们证明,钙黏蛋白-16最小启动子在甲状腺细胞和肾脏细胞中均具有转录活性,Pax8能够激活钙黏蛋白-16启动子报告基因构建体的转录,更重要的是,Pax8确实能够在体内与钙黏蛋白-16启动子区域结合。此外,通过在甲状腺细胞中进行Pax8 RNA干扰以及分析Pax8基因敲除小鼠,我们证明Pax8在体内也调节钙黏蛋白-16的表达。最后,我们发现钙黏蛋白-16的表达在FRTL-5甲状腺细胞中依赖于促甲状腺激素(TSH),并且在小鼠甲状腺癌中显著降低。因此,我们得出结论,钙黏蛋白-16是转录因子Pax8的一个新的下游靶点,可能自甲状腺发育的早期阶段起就是如此,并且其表达与甲状腺细胞的完全分化状态相关。